Cite
HARVARD Citation
Jubb, B. et al. (2019). Incidence of CXCR4 tropism and CCR5-tropic resistance in treatment-experienced participants receiving maraviroc in the 48-week MOTIVATE 1 and 2 trials. Antiviral chemistry & chemotherapy. p. . [Online].